Treatment of actinic keratoses and cancerization field of the face and scalp with 0 015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
An. bras. dermatol; 94 (3), 2019
Abstract: Background: Actinic keratosis (AK) represents a risk of progression to squamous cell carcinoma. Ingenol mebutate gel is a novel therapeutic option for field-directed treatment. Objectives: To evaluate the safety, tolerability and patients' perspectives, related to the therapeutic success of m...
Administración Cutánea, Brasil, Fármacos Dermatológicos/uso terapéutico, Diterpenos/uso terapéutico, Dermatosis Facial/tratamiento farmacológico, Geles/uso terapéutico, Queratosis Actínica/tratamiento farmacológico, Estudios Retrospectivos, Dermatosis del Cuero Cabelludo/tratamiento farmacológico, Encuestas y Cuestionarios, Resultado del Tratamiento